Rheumatoid arthritis does not affect only the joints: Lung symptoms that should not be ignored
Shortness of breath, a dry cough and fatigue can be signs of interstitial lung disease, one of the most serious complications of rheumatoid arthritis Most people with rheumatoid arthritis associate the disease mainly with pain, swelling and limited joint mobility. However, rheumatoid arthritis is a systemic inflammatory disease and can also affect […]
Shortness of breath, a dry cough and fatigue can be signs of interstitial lung disease, one of the most serious complications of rheumatoid arthritis
Most people with rheumatoid arthritis associate the disease mainly with pain, swelling and limited joint mobility. However, rheumatoid arthritis is a systemic inflammatory disease and can also affect other organs, including the lungs.
One of the most significant pulmonary complications is rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Prevalence estimates vary depending on the method of diagnosis: a large recent review found that figures can vary widely, while studies with a lower risk of bias suggest that around 10 percent of patients may have clinically relevant RA-ILD.
What is pulmonary fibrosis?
Pulmonary fibrosis means the formation of scar tissue in the lungs. Over time, lung tissue can become thicker and less elastic, making it harder to breathe and for oxygen to pass into the blood.
The most common signs include:
shortness of breath, especially during physical activity;a dry, persistent cough;fatigue and reduced tolerance for activity.
The problem is that these symptoms are not specific to interstitial lung disease and may also occur in many other conditions. For this reason, lung involvement may go unnoticed in the early stages.
Why can rheumatoid arthritis affect the lungs?
Rheumatoid arthritis causes chronic inflammation that is not limited to the joints. In some patients, the inflammatory process can also involve lung tissue and, in certain cases, lead to fibrotic damage.
RA-ILD is associated with an increased risk of serious complications and higher mortality compared with rheumatoid arthritis without interstitial lung involvement.
Early detection matters
The guidelines of the American College of Rheumatology and the American College of Chest Physicians recommend that people with systemic rheumatic diseases who are at increased risk of ILD be assessed with pulmonary function tests and, as appropriate, high-resolution computed tomography (HRCT). Auscultation alone or a history of symptoms is not sufficient to rule out the disease.
Therefore, a person with rheumatoid arthritis who notices new shortness of breath, a persistent dry cough or a marked decline in physical capacity should report these symptoms to their doctor. Early assessment can help identify lung involvement and plan appropriate treatment and monitoring. /Telegrafi















